Dark

ANVS
Annovis Bio, Inc.
stock NYSE

At Close

Jul 17, 2025 3:59:30 PM EDT

2.82USD+2.920%(+0.08)306,909

2.81Bid 2.83Ask 0.02Spread

Pre-market

Jul 17, 2025 8:29:30 AM EDT

2.79USD+1.730%(+0.05)3,421

After-hours

Jul 16, 2025 4:16:30 PM EDT

2.84USD+2.104%(+0.06)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

54.95M

Headquarters

Berwyn, Pennsylvania, USA

Industry

Biotechnology

Next Earnings

Aug 12, 2025 (26d)

ANVS Stats

Avg. Vol. 10 Day

330,069

Avg. Vol. 30 Day

521,769

Market Cap

54,951,171

Shares Out.

19,486,231

On/Off Exchange

40%/60%

6 Month Beta

1.36

1 Year Beta

1.46

2 Year Beta

1.54

3 Year Beta

1.34

52 Week Low

1.11

52 Week High

13.38

SMA50

2.37

SMA200

4.11

1 Week

-1.05%

1 Month

+7.22%

3 Month

+131.15%

6 Month

-43.71%

1 Year

-77.37%

2 Year

-79.14%

5 Year

-53.85%

Profile

annovis bio, inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. its lead compound is anvs401, which is in phase 2a clinical trials for the treatment of alzheimer's disease (ad), parkinson's disease, alzheimer's disease in down syndrome, and other chronic neurodegenerative disorders. the company is also developing anvs405 for protecting the brain after traumatic brain injury and/or stroke; and anvs301, which is in phase i clinical trials to increase cognitive capability in later stages of ad and dementia. annovis bio, inc. was founded in 2008 and is based in berwyn, pennsylvania.

ANVS Stock Summary

Annovis Bio, Inc. (NYSE:ANVS) stock price today is $2.82, and today's volume is 306,909. ANVS is up 2.920% today. The 30 day average volume is 521,769. ANVS market cap is 54.95M with 19,486,231 shares outstanding.

.dark-mode .zJF5rD{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .zJF5rD{ color: #333333; background-color: white; border: 2px solid #333333; }ANVSAnnovis Bio, Inc.stock NYSE

ANVS Stock Summary

ANVS
Annovis Bio, Inc.
stock NYSE